ArticleHaematologica2019

Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia.

Michael R McKeown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.